Hyperomosis of endolymph as primary pathogenic mechanism of Menière's disease and its clinical management.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D001205:Ascorbic Acid / Q000627:therapeutic use; D007758:Ear, Inner / Q000473:pathology; D006025:Glycosaminoglycans / Q000378:metabolism; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000032:analysis; D007761:Labyrinthine Fluids / Q000201:enzymology / Q000378:metabolism / Q000503:physiopathology*; D008575:Meniere Disease / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D011239:Prednisolone / Q000627:therapeutic use; D011506:Proteins / Q000378:metabolism / Q000627:therapeutic use; D014803:Vitamin B Complex / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D006025:Glycosaminoglycans; D006728:Hormones; D011506:Proteins; D014803:Vitamin B Complex; D011239:Prednisolone; D006821:Hyaluronoglucosaminidase; D001205:Ascorbic Acid